J. Mick Tilford
University of Arkansas for Medical Sciences
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by J. Mick Tilford.
Obesity | 2011
Rebecca A. Krukowski; J. Mick Tilford; Jean Harvey-Berino; Delia Smith West
The objective of this study was to assess the costs associated with a group behavioral weight loss intervention and compare cost‐effectiveness based on treatment delivery modality (in‐person vs. Internet). A randomized controlled trial examined efficacy of a group behavioral obesity intervention across in‐person and Internet treatment modalities. Participants (N = 323, 93% women, mean BMI = 35.8) from two centers were randomized to treatment modality, and contact time was matched between conditions. Primary outcome was weight loss. Cost‐effectiveness measures calculated life years gained (LYG) from changes in weight at 6 months, based on excess years of life lost (YLL) algorithm and the cost of the two modalities. In‐person participants had significantly greater weight losses (−8.0 ± 6.1 kg) than Internet participants (−5.5 ± 5.6 kg), whereas differences in LYG were insignificant. Estimated LYG was 0.58 (95% confidence interval: 0.45, 0.71) and 0.47 (95% confidence interval: 0.34, 0.60) for the in‐person and Internet condition, respectively. Total cost of conducting the in‐person condition was
American Journal of Preventive Medicine | 2016
Scott D. Grosse; Robert J. Berry; J. Mick Tilford; James E. Kucik; Norman J. Waitzman
706 per person and the Internet condition was
Expert Review of Pharmacoeconomics & Outcomes Research | 2012
Nalin Payakachat; J. Mick Tilford; Erica Kovacs; Karen Kuhlthau
372 per person with the difference mainly due to increased travel cost of
Journal of Autism and Developmental Disorders | 2014
Renske J. Hoefman; Nalin Payakachat; Job van Exel; Karen Kuhlthau; Erica Kovacs; Jeffrey M. Pyne; J. Mick Tilford
158 per person. The incremental cost‐effectiveness ratio was
Psychology of Addictive Behaviors | 2015
Alan J. Budney; Catherine Stanger; J. Mick Tilford; Emily B. Scherer; Pamela C. Brown; Zhongze Li; Zhigang Li; Denise D. Walker
2,160 per (discounted) LYG for the Internet modality relative to no intervention/no weight loss and
Contemporary Clinical Trials | 2015
Karen Hye-cheon Kim Yeary; Carol E. Cornell; Elaine Prewitt; Zoran Bursac; J. Mick Tilford; Jerome Turner; Kenya Eddings; Sha Rhonda Love; Emily Whittington; Kimberly Harris
7,177 per (discounted) LYG for the in‐person modality relative to the Internet modality. Participant time costs are recognized as an important cost of medical and behavioral interventions. When participant time costs are included in an economic evaluation of a behavioral weight loss intervention, Internet‐based weight loss delivery may be a more cost‐effective approach to obesity treatment.
Autism Research | 2014
Nalin Payakachat; J. Mick Tilford; Karen Kuhlthau; N. Job A. van Exel; Erica Kovacs; Jayne Bellando; Jeffrey M. Pyne; Werner Brouwer
INTRODUCTION Although fortification of food with folic acid has been calculated to be cost saving in the U.S., updated estimates are needed. This analysis calculates new estimates from the societal perspective of net cost savings per year associated with mandatory folic acid fortification of enriched cereal grain products in the U.S. that was implemented during 1997-1998. METHODS Estimates of annual numbers of live-born spina bifida cases in 1995-1996 relative to 1999-2011 based on birth defects surveillance data were combined during 2015 with published estimates of the present value of lifetime direct costs updated in 2014 U.S. dollars for a live-born infant with spina bifida to estimate avoided direct costs and net cost savings. RESULTS The fortification mandate is estimated to have reduced the annual number of U.S. live-born spina bifida cases by 767, with a lower-bound estimate of 614. The present value of mean direct lifetime cost per infant with spina bifida is estimated to be
Expert Review of Pharmacoeconomics & Outcomes Research | 2015
J. Mick Tilford; Nalin Payakachat
791,900, or
American Journal of Public Health | 2015
Sharla A. Smith; Glen P. Mays; Holly C. Felix; J. Mick Tilford; Geoffrey M. Curran; Michael A. Preston
577,000 excluding caregiving costs. Using a best estimate of numbers of avoided live-born spina bifida cases, fortification is estimated to reduce the present value of total direct costs for each years birth cohort by
Medical Care | 2017
Hsueh-Fen Chen; Saleema Karim; Fei Wan; Adrienne Nevola; Michael E. Morris; T. Mac Bird; J. Mick Tilford
603 million more than the cost of fortification. A lower-bound estimate of cost savings using conservative assumptions, including the upper-bound estimate of fortification cost, is